Skip to main content

Closed

UNCY: Unicycive Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-77.5%

Financially safe

Stretched

Debt / equity0.02×

Interest coverage-544.8×

Current ratio2.40×

Unicycive Therapeutics, Inc.

UNCYNASDAQ Capital Market·USD·Closed

Unicycive Therapeutics, Inc.

UNCYNASDAQ·USD·Closed

$5.01

−5.47%

$5.01

−$0.29 (5.47%)

52W Range

26thpctl

Volume

0.32×avg

Mkt Cap

133.77MUSD

P/E

-2.4TTM

Div Yield

–ann

52W Range

26thpctl

Volume

0.32×avg

Market Cap

133.77MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings